Ceftazidime retains in vivo efficacy against strains of Stenotrophomonas maltophilia for which traditional testing predicts resistance
ABSTRACT Stenotrophomonas maltophilia is responsible for a growing number of nosocomial infections and is difficult to treat owing to limited antibiotic susceptibilities. However, there are numerous recently published examples where traditional susceptibility testing methodology fails to accurately...
Saved in:
Main Authors: | Matthew C. Phillips, Bosul Lee, Sarah L. Miller, Jun Yan, Kristine Goy, Marlène Maeusli, Tina Lam, Catherine Spellberg, Michael Spellberg, Rosemary She, Brad Spellberg, Brian Luna |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2025-06-01
|
Series: | mSphere |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/msphere.00840-24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Piperacillin-tazobactam: prospects for use in real-world practice
by: Yu. M. Gomon
Published: (2023-10-01) -
In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic <i>E. coli</i>
by: Ali Atoom, et al.
Published: (2025-06-01) -
Ceftazidime/avibactam as a possible treatment option for carbapenem-resistant Enterobacterales infections
by: Ana Kaftandzieva, et al.
Published: (2025-12-01) -
Rationale for contemporary antimicrobial treatment of Stenotrophomonas maltophilia: a narrative review
by: John Turnidge, et al.
Published: (2025-06-01) -
Stenotrophomonas Maltophilia Necrotizing Soft Tissue Infection in an Acute Myeloid Leukemia Patient
by: Xu H, et al.
Published: (2025-06-01)